Gene: PLK2
Official Full Name: polo like kinase 2provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the polo family of serine/threonine protein kinases that have a role in normal cell division. This gene is most abundantly expressed in testis, spleen and fetal tissues, and its expression is inducible by serum, suggesting that it may also play an important role in cells undergoing rapid cell division. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08174 | PLK2 Knockout cell line (HeLa) | Human | PLK2 | 1:3~1:6 | Negative | Online Inquiry |
KO08175 | PLK2 Knockout cell line (HCT 116) | Human | PLK2 | 1:2~1:4 | Negative | Online Inquiry |
KO08176 | PLK2 Knockout cell line (HEK293) | Human | PLK2 | 1:3~1:6 | Negative | Online Inquiry |
KO08177 | PLK2 Knockout cell line (A549) | Human | PLK2 | 1:3~1:4 | Negative | Online Inquiry |
PLK2 Gene Knockout Cell Lines are genetically modified cell lines wherein the Polo-like kinase 2 (PLK2) gene has been inactivated or "knocked out" to study the role of this kinase in cellular processes. PLK2 is a serine/threonine kinase that plays a crucial role in cell cycle regulation, mitotic progression, and response to DNA damage. By eliminating the expression of the PLK2 protein, these cell lines allow researchers to explore the functional consequences of PLK2 deficiency, providing insight into its role in cancer biology, neurodegenerative disorders, and other pathophysiological conditions.
The primary mechanism of action in PLK2 involves its regulation of various signaling pathways that impact cell proliferation and survival. The knockout of PLK2 can lead to altered cell cycle dynamics, increased genomic instability, and differential responses to anti-cancer treatments. Utilizing these cell lines, researchers can gain deeper insights into the pathways modulated by PLK2, aiding in the development of targeted therapies.
The scientific importance of PLK2 Gene Knockout Cell Lines extends to both basic and translational research. In clinical settings, understanding the impact of PLK2 can help delineate tumor biology and therapeutic responses, particularly in cancers where PLK2 is dysregulated. The ability to effectively silence this gene opens new avenues for drug discovery and biomarker identification.
Compared to traditional models, PLK2 Gene Knockout Cell Lines offer distinct advantages such as specificity and reproducibility. They eliminate confounding factors associated with native gene expression, allowing for a clearer understanding of PLK2’s role. Furthermore, these lines can be easily integrated into existing experimental workflows, making them a practical choice for laboratories aiming to delve into gene function analysis.
For researchers, clinicians, and pharmaceutical companies, adopting PLK2 Gene Knockout Cell Lines can provide invaluable insights into cellular mechanisms, facilitating groundbreaking discoveries and advancements in therapeutic strategies. Our company, with its robust expertise in developing high-quality biological products, is committed to supporting scientific progress through innovative solutions that empower researchers in their quest for knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.